This page lists the SEC filings reported by Zanganeh Mahkam.
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13D/A | 2023-03-13 | Zanganeh Mahkam | Summit Therapeutics Inc. | 36,882,393 | 5.3% | EDGAR |
SC 13D/A | 2020-11-25 | Zanganeh Maky | Summit Therapeutics Inc. | 5,483,282 | 6.6% | EDGAR |
SC 13D/A | 2020-11-10 | Zanganeh Maky | Summit Therapeutics Inc. | 5,479,959 | 6.6% | EDGAR |
SC 13D | 2020-09-28 | Zanganeh Maky | Summit Therapeutics Inc. | 5,330,258 | 7.8% | EDGAR |
SC 13D | 2020-01-23 | Zanganeh Maky | Summit Therapeutics plc | 24,202,220 | 7.1% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.